General Administration of Press and Publication

Aeterna Zentaris Reports Third Quarter 2023 Financial Results

Retrieved on: 
Donnerstag, November 9, 2023

TORONTO, ONTARIO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the quarter ended September 30, 2023.

Key Points: 
  • - Ended the quarter with $38.8 million in cash, expected to fund operations and advancement of priority pipeline programs into 2025
    TORONTO, ONTARIO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today reported its financial and operating results for the quarter ended September 30, 2023.
  • Dollars
    The Company had $38.8 million in cash and cash equivalents at September 30, 2023.
  • Our total revenue for the nine-month period ended September 30, 2023, was $4.4 million as compared to $3.2 million for the same period in 2022, representing an increase of $1.2 million.
  • For reference, the Company’s Management's Discussion and Analysis of Financial Condition and Results of Operations for the third quarter 2023, as well as the Company's unaudited consolidated interim financial statements as of September 30, 2023, will be available on the Company's website ( www.zentaris.com ) in the Investors section or at the Company's profile at www.sedarplus.com and www.sec.gov .

Wolverine Worldwide Reports Third Quarter Results In-Line With Expectations

Retrieved on: 
Donnerstag, November 9, 2023

Inventory at the end of the quarter was $563.8 million and was down approximately 33% compared to the prior year.

Key Points: 
  • Inventory at the end of the quarter was $563.8 million and was down approximately 33% compared to the prior year.
  • Net Debt at the end of the quarter was $930 million, and liquidity was approximately $400 million.
  • Measures referred to in this release as “adjusted” financial results and the financial results of the "ongoing business" are non-GAAP measures.
  • The Company will host a conference call today at 8:30 a.m. EST to discuss these results and current business trends.

Global Net Lease Reports Third Quarter 2023 Results

Retrieved on: 
Dienstag, November 7, 2023

NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Global Net Lease, Inc. (NYSE: GNL) ("GNL" or the "Company"), an internally managed real estate investment trust that focuses on acquiring and managing a globally diversified portfolio of strategically-located commercial real estate properties, announced today its financial and operating results for the quarter ended September 30, 2023.

Key Points: 
  • As of September 30, 2023, the Company's portfolio of 1,304 net lease properties is located in eleven countries and territories, and is comprised of 66.8 million rentable square feet.
  • As of September 30, 2023, the percentage of debt that is fixed rate (including variable rate debt fixed with swaps) was 82% compared to 74.8% as of September 30, 2022.
  • Weighted-average debt maturity was 3.4 years as of September 30, 2023 as compared to 4.2 years as of September 30, 2022.
  • 4 Weighted-average remaining lease term in years is based on square feet as of September 30, 2023.

Codexis Reports Third Quarter 2023 Financial Results

Retrieved on: 
Donnerstag, November 2, 2023

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the third quarter ended September 30, 2023, and provided a business update.

Key Points: 
  • Company to Host Virtual ECO Synthesis™ Platform-Focused KOL Event on December 8, 2023, featuring John Maraganore
    REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the third quarter ended September 30, 2023, and provided a business update.
  • Including enzyme sales related to PAXLOVID™, total revenues were $9.3 million in third quarter 2023 compared to $34.5 million in third quarter 2022.
  • Including enzyme sales related to PAXLOVID™, product revenues were $5.4 million in third quarter 2023 compared to $28.0 million in third quarter 2022.
  • Product gross margin, excluding enzyme sales related to PAXLOVID™, was 58% for third quarter 2023 compared to 55% in third quarter 2022.

Kontoor Brands Reports 2023 Third Quarter Results; Updates 2023 Outlook

Retrieved on: 
Donnerstag, November 2, 2023

And we delivered another solid quarter in DTC, a critical growth pillar of our diversified, accretive growth strategy,” said Scott Baxter, President, Chief Executive Officer and Chair of Kontoor Brands.

Key Points: 
  • And we delivered another solid quarter in DTC, a critical growth pillar of our diversified, accretive growth strategy,” said Scott Baxter, President, Chief Executive Officer and Chair of Kontoor Brands.
  • Late in the third quarter of 2023, management identified inaccuracies in processing certain transactions with U.S. Customs and Border Protection (“U.S.
  • These inaccuracies resulted in underpayment of certain duties owed to U.S. Customs for the 2021 to 2023 periods.
  • Kontoor Brands will host its third quarter conference call beginning at 8:30 a.m. Eastern Time today, November 2, 2023.

Dr. Reddy’s Q2 FY24 Financial Results

Retrieved on: 
Freitag, Oktober 27, 2023

Q2 FY24 revenue at Rs.

Key Points: 
  • Q2 FY24 revenue at Rs.
  • Q2 FY24 revenue at Rs.
  • Q2 FY24 revenue at Rs.
  • Net Finance income for Q2 FY24 at Rs.1.2 billion compared to net finance expense of Rs.

RETRANSMISSION: HIVE Digital Provides September 2023 Production Update and Purchase of 1,000 S19k Pro ASICs

Retrieved on: 
Freitag, Oktober 6, 2023

Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (the "Company" or "HIVE") is pleased to announce the unaudited production figures from the Company's global Bitcoin operations for the month of September 2023, with 269.5 Bitcoin produced in September. The Company has maintained over 3.83 Exahash ("EH/s") of Bitcoin mining capacity on average for September 2023, including ASIC and GPU BTC hashrate (all amounts in US dollars, unless otherwise indicated).

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (the "Company" or "HIVE") is pleased to announce the unaudited production figures from the Company's global Bitcoin operations for the month of September 2023, with 269.5 Bitcoin produced in September.
  • Our team's track record, couple with our fiscal prudence, puts us in a strong position to weather the halving event next April.
  • Our focus is to maximize ROI on Bitcoin mining ASICs we purchase now, by making strategic acquisitions of only the very best offers in the market."
  • Mr. Holmes, HIVE's Executive Chairman, added, "We're laser focused on acquiring high-efficiency Bitcoin mining rigs at the best possible price.

HIVE Digital Provides September 2023 Production Update and Purchase of 1,000 S19k Pro ASICs

Retrieved on: 
Freitag, Oktober 6, 2023

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated August 17, 2023, to its short form base shelf prospectus dated May 1, 2023.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (the "Company" or "HIVE") is pleased to announce the unaudited production figures from the Company's global Bitcoin operations for the month of September 2023, with 269.5 Bitcoin produced in September.
  • Our focus is to maximize ROI on Bitcoin mining ASICs we purchase now, by making strategic acquisitions of only the very best offers in the market."
  • The Company notes this variance in ROI is accounted for by purchase price and delivery date.
  • Mr. Holmes, HIVE's Executive Chairman, added, "We're laser focused on acquiring high-efficiency Bitcoin mining rigs at the best possible price.

NEXE Innovations Announces Financial Results for the Twelve-Month Period Ended May 31, 2023

Retrieved on: 
Freitag, September 29, 2023

VANCOUVER, BC, Sept. 28, 2023 /PRNewswire/ - NEXE Innovations Inc. ("NEXE" or the "Company") (TSXV: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a compostable and innovative materials company, is pleased to announce its financial results for the twelve-month and three-month period ended May 31, 2023 ("Q4 2023").

Key Points: 
  • VANCOUVER, BC, Sept. 28, 2023 /PRNewswire/ - NEXE Innovations Inc. ("NEXE" or the "Company") (TSXV: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a compostable and innovative materials company, is pleased to announce its financial results for the twelve-month and three-month period ended May 31, 2023 ("Q4 2023").
  • Fiscal 2023 was a pivotal year for NEXE Innovations, with several key accomplishments.
  • The Company has transitioned into production and, subsequent to year-end, as previously announced, has onboarded three co-manufacturing customers – a key segment for NEXE.
  • The Company received its occupancy permit, installed and tested key equipment, and started to build out the operations team in March 2023.

Kaival Brands Reports Fiscal 2023 Third Quarter Financial Results and Highlights Recent Achievements

Retrieved on: 
Mittwoch, September 20, 2023

GRANT-VALKARIA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive U.S. distributor of all products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), including the BIDI® Stick, which are intended for adults 21 and over, today announced its financial results for the fiscal 2023 third quarter ended July 31, 2023.

Key Points: 
  • GRANT-VALKARIA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive U.S. distributor of all products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), including the BIDI® Stick, which are intended for adults 21 and over, today announced its financial results for the fiscal 2023 third quarter ended July 31, 2023.
  • The increase in gross profit was primarily driven by improved cost per sticks during the third quarter of fiscal year 2023.
  • Operating Expenses: Total operating expenses were $3.0 million for the third quarter of fiscal year 2023, compared to $4.3 million for the third quarter of fiscal year 2022.
  • Cash Position: As of July 31, 2023, the Company had working capital of $2.4 million and total cash of $1.0 million.